Skip to main content
Top
Published in: Immunologic Research 4-5/2019

01-10-2019 | Brief report

X-linked hyper-IgM syndrome complicated with interstitial pneumonia and liver injury: a new mutation locus in the CD40LG gene

Authors: Tian-Jiao Wang, Li-Fang Wu, Junguo Chen, Wen Zhu, Hua Wang, Xiao-Lin Liu, Yi-Qun Teng

Published in: Immunologic Research | Issue 4-5/2019

Login to get access

Excerpt

X-linked hyper-IgM syndrome (HIGM1) is a rare primary immunodeficiency syndrome caused by mutations in the CD40L gene. The major clinical feature of the disease is repeated opportunistic infections; however, in rare cases, presentation is with interstitial lung lesions complicated with liver injury. Herein, we present a case of a 5-month-old child presented with a prolonged cough with difficulty breathing. The clinical presentation of the child included progressive pulmonary interstitial changes and liver damage. Testing revealed a lack of IgA and a decrease in IgM level. Whole-exome sequencing revealed that there was a homozygous mutation in exon 5 of the CD40LG gene (c.685T>C, F229L). The child’s mother carried a heterozygous mutation at this locus. The child was diagnosed with HIGM1, and the mutation locus is chrX:135741473, a novel mutation site in CD40LG. The onset of this disease is occult, but it progresses rapidly. It is rare to report lung interstitial changes combined with liver damage. Gene testing is the gold standard for diagnosis. Hematopoietic stem cell transplantation is currently the most effective treatment. …
Literature
1.
go back to reference De la Morena MT, Leonard D, Torgerson TR, Cabral-Marques O, Slatter M, Aghamohammadi A, et al. Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation. J Allergy Clin Immunol. 2017;139:1282–92.CrossRef De la Morena MT, Leonard D, Torgerson TR, Cabral-Marques O, Slatter M, Aghamohammadi A, et al. Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation. J Allergy Clin Immunol. 2017;139:1282–92.CrossRef
2.
go back to reference De la Morena MT. Clinical phenotypes of hyper-IgM syndromes. J Allergy Clin Immunol Pract. 2016;4:1023–36.CrossRef De la Morena MT. Clinical phenotypes of hyper-IgM syndromes. J Allergy Clin Immunol Pract. 2016;4:1023–36.CrossRef
3.
go back to reference Barbouche M, Chen Q, Carbone M, Ben-Mustapha I, Shums Z, Trifa M, et al. Comprehensive review of autoantibodies in patients with hyper-IgM syndrome. Cell Mol Immunol. 2018;15:610–7.CrossRef Barbouche M, Chen Q, Carbone M, Ben-Mustapha I, Shums Z, Trifa M, et al. Comprehensive review of autoantibodies in patients with hyper-IgM syndrome. Cell Mol Immunol. 2018;15:610–7.CrossRef
4.
go back to reference Kuo CY, Long JD, Campo-Fernandez B, De Oliveira S, Cooper AR, Romero Z, et al. Site-specific gene editing of human hematopoietic stem cells for X-linked hyper-IgM syndrome. Cell Rep. 2018;23:2606–16.CrossRef Kuo CY, Long JD, Campo-Fernandez B, De Oliveira S, Cooper AR, Romero Z, et al. Site-specific gene editing of human hematopoietic stem cells for X-linked hyper-IgM syndrome. Cell Rep. 2018;23:2606–16.CrossRef
5.
go back to reference Meng X, Yang B, Suen WC. Prospects for modulating the CD40/CD40L pathway in the therapy of the hyper-IgM syndrome. Innate immunity. 2018;24:4–10.CrossRef Meng X, Yang B, Suen WC. Prospects for modulating the CD40/CD40L pathway in the therapy of the hyper-IgM syndrome. Innate immunity. 2018;24:4–10.CrossRef
6.
go back to reference Ouair H, Benhsaien I, Jeddane L, El Bakkouri J, Elhafidi N, Rada N, et al. [Clinical and immunological profile of 15 Moroccan patients with Hyper IgM syndrome]. The Pan African medical journal. 2017;26:212. Ouair H, Benhsaien I, Jeddane L, El Bakkouri J, Elhafidi N, Rada N, et al. [Clinical and immunological profile of 15 Moroccan patients with Hyper IgM syndrome]. The Pan African medical journal. 2017;26:212.
7.
go back to reference Torabizadeh M, Nabavi M, Zadkarami M, Shahrooei M. X-linked hyper-IgM syndrome associated with pulmonary manifestations: a very rare case of functional mutation in CD40L gene in Iran. Current research in translational medicine. 2018:S2452–3186. Torabizadeh M, Nabavi M, Zadkarami M, Shahrooei M. X-linked hyper-IgM syndrome associated with pulmonary manifestations: a very rare case of functional mutation in CD40L gene in Iran. Current research in translational medicine. 2018:S2452–3186.
8.
go back to reference Acker KP, Fetch A, Schnell SA, Hammond J, Herrera C, Niedt G, et al. Scalp lesions in a pediatric patient with hyper IgM syndrome: clinical and histologic mimicry of Cryptococcus neoformans infection. J Pediatr. 2018;192:256–8.CrossRef Acker KP, Fetch A, Schnell SA, Hammond J, Herrera C, Niedt G, et al. Scalp lesions in a pediatric patient with hyper IgM syndrome: clinical and histologic mimicry of Cryptococcus neoformans infection. J Pediatr. 2018;192:256–8.CrossRef
9.
go back to reference Gallagher J, Adams J, Hintermeyer M, Torgerson TR, Lopez-Guisa J, Ochs HD, et al. X-linked hyper IgM syndrome presenting as pulmonary alveolar proteinosis. J Clin Immunol. 2016;36:564–70.CrossRef Gallagher J, Adams J, Hintermeyer M, Torgerson TR, Lopez-Guisa J, Ochs HD, et al. X-linked hyper IgM syndrome presenting as pulmonary alveolar proteinosis. J Clin Immunol. 2016;36:564–70.CrossRef
10.
go back to reference Jesenak M, Banovcin P, Jesenakova B, Babusikova E. Pulmonary manifestations of primary immunodeficiency disorders in children. Front Pediatr. 2014;2:77.CrossRef Jesenak M, Banovcin P, Jesenakova B, Babusikova E. Pulmonary manifestations of primary immunodeficiency disorders in children. Front Pediatr. 2014;2:77.CrossRef
11.
go back to reference Cham B, Bonilla MA, Winkelstein J. Neutropenia associated with primary immunodeficiency syndromes. Semin Hematol. 2002;39:107–12.CrossRef Cham B, Bonilla MA, Winkelstein J. Neutropenia associated with primary immunodeficiency syndromes. Semin Hematol. 2002;39:107–12.CrossRef
12.
go back to reference Mavroudi I, Papadaki HA. The role of CD40/CD40 ligand interactions in bone marrow granulopoiesis. TheScientificWorldJournal. 2011;11:2011–9.CrossRef Mavroudi I, Papadaki HA. The role of CD40/CD40 ligand interactions in bone marrow granulopoiesis. TheScientificWorldJournal. 2011;11:2011–9.CrossRef
13.
go back to reference Rodrigues F, Davies E, Harrison P, McLauchlin J, Karani J, Portmann B, et al. Liver disease in children with primary immunodeficiencies. J Pediatr. 2004;145:333–9.CrossRef Rodrigues F, Davies E, Harrison P, McLauchlin J, Karani J, Portmann B, et al. Liver disease in children with primary immunodeficiencies. J Pediatr. 2004;145:333–9.CrossRef
14.
go back to reference Lleo A, Liao J, Invernizzi P, Zhao M, Bernuzzi F, Ma L, et al. Immunoglobulin M levels inversely correlate with CD40 ligand promoter methylation in patients with primary biliary cirrhosis. Hepatology. 2012;55:153–60.CrossRef Lleo A, Liao J, Invernizzi P, Zhao M, Bernuzzi F, Ma L, et al. Immunoglobulin M levels inversely correlate with CD40 ligand promoter methylation in patients with primary biliary cirrhosis. Hepatology. 2012;55:153–60.CrossRef
15.
go back to reference Revy P, Muto T, Levy Y, Geissmann F, Plebani A, Sanal O, et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the hyper-IgM syndrome (HIGM2). Cell. 2000;102:565–75.CrossRef Revy P, Muto T, Levy Y, Geissmann F, Plebani A, Sanal O, et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the hyper-IgM syndrome (HIGM2). Cell. 2000;102:565–75.CrossRef
16.
go back to reference Heinold A, Hanebeck B, Daniel V, Heyder J, Tran TH, Dohler B, et al. Pitfalls of “hyper”-IgM syndrome: a new CD40 ligand mutation in the presence of low IgM levels. A case report and a critical review of the literature. Infection. 2010;38:491–6.CrossRef Heinold A, Hanebeck B, Daniel V, Heyder J, Tran TH, Dohler B, et al. Pitfalls of “hyper”-IgM syndrome: a new CD40 ligand mutation in the presence of low IgM levels. A case report and a critical review of the literature. Infection. 2010;38:491–6.CrossRef
17.
go back to reference Winkelstein JA, Marino MC, Ochs H, Fuleihan R, Scholl PR, Geha R, et al. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine. 2003;82:373–84.CrossRef Winkelstein JA, Marino MC, Ochs H, Fuleihan R, Scholl PR, Geha R, et al. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine. 2003;82:373–84.CrossRef
18.
go back to reference Hennig C, Happle C, Hansen G. “A bad wound may heal, but a bad name can kill”--lessons learned from “hyper-IgM syndrome”. J Allergy Clin Immunol 2011;128:1380–1382; author reply 2-3.CrossRef Hennig C, Happle C, Hansen G. “A bad wound may heal, but a bad name can kill”--lessons learned from “hyper-IgM syndrome”. J Allergy Clin Immunol 2011;128:1380–1382; author reply 2-3.CrossRef
19.
go back to reference Lopez-Herrera G, Maravillas-Montero JL, Vargas-Hernandez A, Berron-Ruiz L, Ramirez-Sanchez E, Yamazaki-Nakashimada MA, et al. A novel CD40LG deletion causes the hyper-IgM syndrome with normal CD40L expression in a 6-month-old child. Immunol Res. 2015;62:89–94.CrossRef Lopez-Herrera G, Maravillas-Montero JL, Vargas-Hernandez A, Berron-Ruiz L, Ramirez-Sanchez E, Yamazaki-Nakashimada MA, et al. A novel CD40LG deletion causes the hyper-IgM syndrome with normal CD40L expression in a 6-month-old child. Immunol Res. 2015;62:89–94.CrossRef
20.
go back to reference Mitsui-Sekinaka K, Imai K, Sato H, Tomizawa D, Kajiwara M, Nagasawa M, et al. Clinical features and hematopoietic stem cell transplantations for CD40 ligand deficiency in Japan. J Allergy Clin Immunol. 2015;136:1018–24.CrossRef Mitsui-Sekinaka K, Imai K, Sato H, Tomizawa D, Kajiwara M, Nagasawa M, et al. Clinical features and hematopoietic stem cell transplantations for CD40 ligand deficiency in Japan. J Allergy Clin Immunol. 2015;136:1018–24.CrossRef
21.
go back to reference Allewelt H, Martin PL, Szabolcs P, Chao N, Buckley R, Parikh S. Hematopoietic stem cell transplantation for CD40 ligand deficiency: single institution experience. Pediatr Blood Cancer. 2015;62:2216–22.CrossRef Allewelt H, Martin PL, Szabolcs P, Chao N, Buckley R, Parikh S. Hematopoietic stem cell transplantation for CD40 ligand deficiency: single institution experience. Pediatr Blood Cancer. 2015;62:2216–22.CrossRef
22.
go back to reference Gungor T, Teira P, Slatter M, Stussi G, Stepensky P, Moshous D, et al. Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study. Lancet (London, England). 2014;383:436–48.CrossRef Gungor T, Teira P, Slatter M, Stussi G, Stepensky P, Moshous D, et al. Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study. Lancet (London, England). 2014;383:436–48.CrossRef
23.
go back to reference Jain A, Kovacs JA, Nelson DL, Migueles SA, Pittaluga S, Fanslow W, et al. Partial immune reconstitution of X-linked hyper IgM syndrome with recombinant CD40 ligand. Blood. 2011;118:3811–7.CrossRef Jain A, Kovacs JA, Nelson DL, Migueles SA, Pittaluga S, Fanslow W, et al. Partial immune reconstitution of X-linked hyper IgM syndrome with recombinant CD40 ligand. Blood. 2011;118:3811–7.CrossRef
24.
go back to reference Mazzei GJ, Edgerton MD, Losberger C, Lecoanet-Henchoz S, Graber P, Durandy A, et al. Recombinant soluble trimeric CD40 ligand is biologically active. J Biol Chem. 1995;270:7025–8.CrossRef Mazzei GJ, Edgerton MD, Losberger C, Lecoanet-Henchoz S, Graber P, Durandy A, et al. Recombinant soluble trimeric CD40 ligand is biologically active. J Biol Chem. 1995;270:7025–8.CrossRef
25.
go back to reference Hubbard N, Hagin D, Sommer K, Song Y, Khan I, Clough C, et al. Targeted gene editing restores regulated CD40L function in X-linked hyper-IgM syndrome. Blood. 2016;127:2513–22.CrossRef Hubbard N, Hagin D, Sommer K, Song Y, Khan I, Clough C, et al. Targeted gene editing restores regulated CD40L function in X-linked hyper-IgM syndrome. Blood. 2016;127:2513–22.CrossRef
Metadata
Title
X-linked hyper-IgM syndrome complicated with interstitial pneumonia and liver injury: a new mutation locus in the CD40LG gene
Authors
Tian-Jiao Wang
Li-Fang Wu
Junguo Chen
Wen Zhu
Hua Wang
Xiao-Lin Liu
Yi-Qun Teng
Publication date
01-10-2019
Publisher
Springer US
Published in
Immunologic Research / Issue 4-5/2019
Print ISSN: 0257-277X
Electronic ISSN: 1559-0755
DOI
https://doi.org/10.1007/s12026-019-09098-4

Other articles of this Issue 4-5/2019

Immunologic Research 4-5/2019 Go to the issue